Aadi Bioscience, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$39.6M
Doctors Paid
583
Transactions
2,682
2024 Total
$21.2M
Payment Breakdown by Category
Research$38.8M (97.9%)
Consulting$342,321 (0.9%)
Food & Beverage$51,210 (0.1%)
Travel$29,303 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $38.8M | 1,512 | 97.9% |
| Honoraria | $366,675 | 141 | 0.9% |
| Consulting Fee | $342,321 | 82 | 0.9% |
| Food and Beverage | $51,210 | 827 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,305 | 19 | 0.1% |
| Travel and Lodging | $29,303 | 66 | 0.1% |
| Space rental or facility fees (teaching hospital only) | $14,000 | 4 | 0.0% |
| Education | $5,024 | 31 | 0.0% |
Payments by Type
Research
$38.8M
1,508 transactions
General
$850,838
1,170 transactions
Ownership
$0
4 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/_TSC2 Genes (PRECISION 1) | $14.9M | 0 | 51 |
| Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1TSC2 Genes PRECISION 1 | $7.1M | 0 | 31 |
| Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer | $6.3M | 0 | 327 |
| A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes | $3.7M | 2 | 467 |
| A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes. | $2.7M | 1 | 271 |
| Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors NETs of the Gastrointestinal Tract Lung or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors | $2.5M | 0 | 4 |
| Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract Lung or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors | $494,611 | 0 | 315 |
| Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment | $475,934 | 0 | 23 |
| A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions | $294,203 | 0 | 2 |
| Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas | $218,068 | 0 | 8 |
| A Phase 2 Study of ABI-009 in Patients With Advanced Malignant PEComa | $58,869 | 0 | 5 |
| Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors | $38,440 | 0 | 4 |
Payments by Medical Specialty
Top Paid Doctors — Page 7
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Yovanni Casablanca, Md, MD | Gynecologic Oncology | Charlotte, NC | $238.92 | $0 |
| Cissimol Joseph, Np-C, NP-C | Nurse Practitioner | Houston, TX | $223.91 | $0 |
| Dr. Neal Chawla, M.d./ M.b.b.s, M.D./ M.B.B.S | Hematology & Oncology | Santa Monica, CA | $222.46 | $0 |
| Steven Wong, Md, MD | Hematology & Oncology | Santa Monica, CA | $218.72 | $0 |
| Dr. Grant Jirka, Md, MD | Internal Medicine | Los Angeles, CA | $208.18 | $0 |
| Kenneth Cardona, Md, MD | Surgery | Atlanta, GA | $206.77 | $0 |
| Siddharth Iyengar, Md, MD | Internal Medicine | Salt Lake City, UT | $206.66 | $0 |
| Dr. Robert Edwards, Md, MD | Specialist | Pittsburgh, PA | $203.85 | $0 |
| Robert Edwards | Specialist | Pittsburgh, PA | $203.84 | $0 |
| Dr. Mackenzy Radolec, M.d, M.D | Obstetrics & Gynecology | Pittsburgh, PA | $195.63 | $0 |
| Dr. David Tamura, M.d, M.D | Medical Oncology | Honolulu, HI | $193.64 | $0 |
| Dr. Anna Priebe, M.d, M.D | Obstetrics & Gynecology | Tyler, TX | $188.98 | $0 |
| Ania Moradkhani | Nurse Practitioner | Santa Monica, CA | $186.45 | $0 |
| Dr. Mazen Jizzini, Md, MD | Hematology & Oncology | Tarzana, CA | $182.73 | $0 |
| Yeo Jin Moon, Arnp, ARNP | Family | Seattle, WA | $179.05 | $0 |
| Dr. Andrew Brohl, M.d, M.D | Medical Oncology | Tampa, FL | $177.39 | $0 |
| Dr. Neha Goel, M.d, M.D | Student in an Organized Health Care Education/Training Program | Miami, FL | $171.63 | $0 |
| Dr. Steven Bialick, Do, Ms, DO, MS | Medical Oncology | Deerfield Beach, FL | $168.98 | $0 |
| Nakema Rollins, Crnp, CRNP | Nurse Practitioner | Philadelphia, PA | $160.00 | $0 |
| Ms. Jade Law, Md, MD | Student in an Organized Health Care Education/Training Program | Sylmar, CA | $158.73 | $0 |
| Dr. Vishwanath Ganesan, Md, MD | Student in an Organized Health Care Education/Training Program | Los Angeles, CA | $158.20 | $0 |
| Robert Holloway, Md, MD | Gynecologic Oncology | Orlando, FL | $158.10 | $0 |
| Juliet Wolford, M.d, M.D | Obstetrics & Gynecology | Kettering, OH | $158.09 | $0 |
| Ferdinand Dayalo, Np-C, NP-C | Nurse Practitioner | South El Monte, CA | $156.04 | $0 |
| Erin Crane, Md, MD | Obstetrics & Gynecology | Charlotte, NC | $155.94 | $0 |
About Aadi Bioscience, Inc.
Aadi Bioscience, Inc. has made $39.6M in payments to 583 healthcare providers, recorded across 2,682 transactions in the CMS Open Payments database. In 2024, the company paid $21.2M. The top product by payment volume is FYARRO ($23.1M).
Payments were distributed across 46 medical specialties. The top specialty by payment amount is Medical Oncology ($341,757 to 68 doctors).
Payment categories include: Food & Beverage ($51,210), Consulting ($342,321), Research ($38.8M), Travel & Lodging ($29,303).
Aadi Bioscience, Inc. is associated with 3 products in the CMS Open Payments database.